Background A potential source of bias in epidemiological studies comes from studying people at different stages of disease progression. This can result in biased selection of cases or in errors of measurement of exposures.
Methods
We use stage of disease at the time of diagnosis to evaluate how inclusion of people at different stages in the disease process can influence associations between environmental exposures and colon cancer. Data used were generated from a large case-control study of colon cancer.
Results
For most environmental exposures evaluated, including physical activity, body size, use of aspirin and of non-steroidal anti-inflammatory drugs, and dietary intake of folate and fibre, we did not observe differences in patterns of association by stage of disease at diagnosis. However, for total energy and red meat intake (men only), alcohol consumption, cigarette smoking, and family history of colorectal cancer among first degree relatives, patterns of associations were stronger when colon cancer was detected at an earlier stage of disease progression than when it was detected at a more advanced stage. Conclusions Most exposures did not differ by stage of disease, thus selectively excluding cases at different disease stages should not influence associations between these exposures and colon cancer. Associations for other factors, such as alcohol consumption and cigarette smoking, may be biased from asking cases with advanced disease to recall a non-disease-free time period. Associations with family history may also be biased if those with a family history of colorectal cancer are detected at an earlier stage and therefore more likely to participate in epidemiological studies. Keywords Colonic neoplasia, bias, cigarette smoking, alcohol, family history, tumour stage Accepted 16 September 1997
Epidemiology is a science based on estimation. It involves disentangling true associations between genetic and environmental factors and disease, from those which may be an artefact of bias. The potential for bias in epidemiological studies has been reviewed 1^1 and efforts to reduce and understand bias are key to the design and conduct of epidemiological research. One potential source of bias is selection bias. If the relationship between exposures and disease are different for those who participate versus those who do not participate, distorted estimates of association can occur. 5 If environmental or genetic exposures relate differently to advanced tumours, distorted estimates of association can also result.
There are data to support the belief that colon cancer represents a progression of changing disease severity, with the adenomatous polyp being a precursor to more invasive tumours; 6 this process for most individuals is thought to occur over a period of many years. In a case-control study of colon cancer, selection bias is possible since cases whose disease is further progressed are less likely to participate, although it is possible that disease progression also can introduce information bias. Errors in measurement of pre-disease exposures can occur if the disease has resulted in changes in behaviour, if those most sick because of more advanced tumours recall exposures which occurred in a non-disease-free time period, if cases with advanced disease recall differently because of poor health, or if there are real biological effects associated with various disease stages.
It is reasonable to hypothesize that by studying disease progression, it is possible to have a better understanding of bias associated with the disease process. Disease stage at the time of DISEASE STAGE AND COLON CANCER 383 diagnosis can be used to as an indicator of disease progression. Thus, we use stage at diagnosis as a tool to quantitatively study the impact that disease progression may have on patterns of association between environmental factors and colon cancer. Patterns of association evaluated are: exposures that increase risk of more advanced tumours only, since this may indicate an association with aggressive tumours; exposures which increase risk primarily among those with local disease stage since this can indicate changes in behaviour of those with more advanced disease which results in different exposures as the disease progresses; and exposures that do not differ by stage of disease since this implies that population-based estimates of association are not influenced by disproportionately including or excluding cases at different stages of the disease process.
Methods

Study population
Data for this study come from a large multi-centre study of colon cancer. Included in these analyses are participants identified from the Kaiser Permanente Medical Care Program (KPMPC) of Northern California and an eight county area in Utah. Study participants from the Twin Cities Metropolitan area in Minnesota are not included in these analyses since staging data were not available for all cases identified at that centre. All cases were between the ages of 30 and 79 and had a first primary colon cancer (ICD-O 2nd edition codes 18.0, 18.2 to 18.9) verified through a SEER registry for KPMCP and Utah. Cases of the rectosigmoid junction and rectum were excluded, as were cases with identified familial adenomatous polyposis, ulcerative colitis, or Crohn's disease. Control selection methods have been reported elsewhere;
7 ' 8 at KPMCP controls were randomly selected from membership lists and in Utah controls were identified using Health Care Financing Administration lists (age 65 and older), driver's license list, or random digit dialling. Controls were matched to cases (using a 1:1 matching ratio) by sex and 5-year age groups. Response rates (the proportion of all eligible people identified who participated in the study), cooperation rates (the proportion of all eligible people contacted who participated in the study), and contact rates (the proportion of all eligible people who we were able to contact, i.e. physician refusal and those who were dead are not included in the denominator) were calculated as described; 7 for the KPMCP and Utah centres these rates were 71.8%, 80.8%, and 98.6% respectively for cases and 68.0%, 71.6%, and 95.6% respectively for controls. Despite rapid case-ascertainment (median time from diagnosis to identification was 17 days for KPMCP and 24 days for Utah), of the cases who did not participate (N = 547), 35.8% were too ill to complete the interview or had died before the interview could be completed (N = 196 ). Another 11.2% (N = 61) were not contacted because of physician refusal and 48.6% (N = 266) refused to participate; it is not known what percentage of these groups did not participate because of advanced disease stage.
Data ascertainment
Study participants were interviewed by trained and certified interviewers using a computerized questionnaire. 9 ' 10 The interview lasted approximately 2 hours. The referent period for study questions was the calendar year 2 years before diagnosis for cases or selection for controls. Dietary data were obtained using an adaptation of the validated CARDIA diet history questionnaire 10 " 12 and were converted to nutrient values using the Nutrition Coordinating Center (NCC) nutrient database. 13 Usual alcohol consumption was estimated from the diet history questionnaire; consumption on week days (Monday to Thursday) and weekend days (Friday to Sunday) was reported separately. Physical activity data were obtained using an adaptation of the CARDIA physical activity history; 14 ' 15 similar questions were asked for activity patterns 10 and 20 years before. Other data included: measured height and self-reported weight for the referent period and for 5 years prior to diagnosis; cigarette smoking history (ever having smoked on a regular basis, year started and stopped, and usual amount smoked); reproductive history, hormone replacement therapy (HRT); medical history; drug use history which included questions about aspirin and other nonsteroidal anti-inflammatory drugs (NSATD); and family history of cancer among first degree relatives. This indicator of family history, although not an indicator of high risk families, is a common indicator used in epidemiological studies.
Tumour data
Tumour staging data were available from all eligible colon cancers identified in California and Utah between 1 October 1991 and 30 September 1994. Tumour staging was done by SEER registry staff for 95% of all cases identified using SEER summary staging codes which takes into account tumour size, extent of node involvement, and metastasis. Tumours at a local stage were those which invade the submucosa or muscularis propria, have no lymph node involvement, and no metastasis. Tumours at a regional stage had invaded through the muscularis propria in the subserosa or into non-peritonealized pericolic or perirectal tissues, or had perforated the visceral peritoneum or other organs or structures such as the small intestine, abdominal fat wall or enterperitoneum; they may or may not have regional lymph node involvement. Distant tumours were those which invade other more distant organs such as the gallbladder, diaphragm, adrenal glands or liver, and may or may not have distant lymph node involvement and/or distant metastasis. For approximately 100 cases where SEER staging data were not available, cases were staged using SEER staging criteria by the study pathologist (WS). We used tumour stage to describe colon cancer progression. Cases diagnosed at a local stage were considered early stages of disease progression, while cases diagnosed at a distant stage were considered to be late stages of disease progression.
Statistical methods
To evaluate the differences in risk observed by stage at diagnosis, unconditional logistic regression analyses were done stratifying by disease stage and comparing cases to controls; polychotomous logistic regression models were used to compare cases with regional and distant disease to those diagnosed at a local disease stage and to test for statistically significant differences in exposures. In these models exposure data were categorized based on sex-specific distribution in the control population. Models were adjusted for age, body mass index (BMI), long-term vigorous physical activity, use of NSAID, dietary energy, calcium, fibre, and family history of colorectal cancer. 
Results
Response rates for cases diagnosed at a local or regional stage were approximately 80% among men and 70-75% among women, however, only about 50% of all eligible cases diagnosed at a distant stage participated (Table 1) . While there were no differences in stage at diagnosis by sex of study participants and non-participants, older cases were less likely to participate when diagnosed at a distant stage of disease than were cases less than 50 years of age at the time of diagnosis (Table 2) . Participants with a distant stage of disease were more likely to have proximal rather than distal tumours while non-participants with a distant disease stage were more likely to have distal tumours rather than proximal tumours. For most exposures evaluated, including physical activity level, BMI, dietary intake of folate, fibre, fruit, and vegetables, aspirin and NSAID, and HRT use there were no clear patterns of differences in association for those diagnosed at a local, regional, or distant disease stage. However, for other exposures, including total energy intake and red meat consumption among men, alcohol consumption, number of cigarettes smoked, and family history of colorectal cancer we observed that associations were strongest among those diagnosed at a local stage of disease with patterns of associations becoming weaker as stage of disease at time of diagnosis indicated a more advanced tumour (Table 3) . Men were approximately half as likely to have an elevated risk associated with energy intake or red meat consumption if diagnosed at a distant stage of disease compared to those who were diagnosed at a local disease stage. Cases diagnosed at a distant disease stage were less likely to report high levels of alcohol consumption or a family history of colorectal cancer compared to those diagnosed at a local disease stage. Women diagnosed at a distant stage of disease are half as likely to be in the upper quintile of cigarette smoking as are women who are diagnosed at a local disease stage. Although no statistically significant differences in association were observed for calcium intake, there were suggestions that those with more advanced disease reported more calcium intake; associations were generally stronger among those diagnosed at a local or regional stage, especially among women.
Discussion
There are many possible sources of error in estimating associations in epidemiological studies including selection and information bias. In this study, we have used stage of colon cancer at diagnosis as an indicator of disease progression in order to understand these biases better. Based on results from these analyses, we believe that most exposures are not influenced by disease progression, although some environmental exposures may have stage-specific associations. A basic assumption made in interpreting these patterns of association is that those who did not participate are similar to others who were diagnosed at the same stage of disease as those who did participate. However, since a higher percentage of those diagnosed at a distant disease stage did not participate, there is room for violation of this assumption. Likewise, our sample size of individuals diagnosed at a distant disease stage is smaller than for other disease stages evaluated, making estimates of associations less precise among this group. Since we were unable to evaluate site-specific associations, and study participation and disease progression are associated with tumour site, we may have missed differences in association that exist by tumour site.
As noted by others, selection bias and information bias (as demonstrated through errors in measurement) can be present in both case-control and cohort studies.
2 Differential participation because of disease stage has been demonstrated in both case-control and cohort studies. In the case-control design, those diagnosed at a more distant stage are less likely to participate because of advanced disease, illness and possible death prior to the interview. In the cohort study design, it is possible that those identified with cancer have more advanced disease stage if the National Death Index is used as a method of case identification since those with more advanced disease are more likely to die from the disease. Our case-control data show that despite a rapid-reporting system, the majority of cases who do not participate were diagnosed at an advanced disease stage. Data from the Iowa Women's Health Study which uses the Iowa SEER registry for case identification, have similar distributions of colon cancer by disease stage as we report; 34% of our population were diagnosed at a local stage and 36.4% of colon cases from the Iowa Women's Health Study were diagnosed at a local disease stage (Folsom AR, personnel communication), while data from the Nurses Health Study have shown that 17% of colon cases are diagnosed at a local disease stage; the National Death Index is used as a method to ascertain cases in that study. 16 However, despite the possibility of selection bias because of differentially excluding cases diagnosed at a distant disease stage, we do not believe that most associations with colon cancer have been distorted because of the exclusions.
Our data suggest that information bias resulting from errors of measurement of some exposures, may exist as a result of disease progression, since associations are weaker for those diagnosed when the tumour has progressed further. Exposures which reflect possible changes in behaviour because of illness are: reducing total energy intake and red meat consumption, and possibly increasing calcium intake; decreasing number of cigarettes smoked among women; and decreasing alcohol consumption among men and women. Our observation for cigarette smoking is opposite to that reported elsewhere, where it was suggested that tobacco use may lead to more advanced disease stage. 17 As noted, there are some differences in these patterns between men and women. For instance energy intake and red meat appear to be associated more with local disease stage among men only and differences in associations with cigarette smoking appear to be most marked among women. Although reasons for these differences are speculative, it is possible that since red meat consumption is higher among men than women, a greater difference by disease stage is detectable. Likewise, it is possible that men and women exhibit different behaviours when they feel unwell in that men reduce their overall level of energy intake while women do not. Since women in this study generally did not smoke a lot, it may have been easier for them to stop smoking when they felt unwell than it was for men.
While it is difficult to envision a biological process whereby factors relate only to local but not to more advanced tumours, it is possible that information bias associated with errors in measurement could account for the observation. The referent period for a case-control study or the time between exposure and diagnosis for a cohort study may have a different meaning for someone diagnosed when the tumour has progressed to more advanced disease than for someone whose tumour is small and confined. In light of this, the error in measurement is most likely from those diagnosed with advanced disease being asked to recall exposures for a non-disease-free time period. We believe that this measurement error is not the result of being a case, since differences in associations are observed among cases diagnosed at different stages of the disease process. Therefore, we believe that this potential error in measurement pertains both to case-control and cohort studies. It should not be viewed as an error of recall because of case status, but rather as a bias stemming from the design, since cases were most probably asked to recall exposures for a time when they were not disease free.
Family history of colorectal cancer also appears to be more strongly related to colon cancer among cases diagnosed at earlier stages of disease progression than among cases diagnosed when the tumour was at a local stage of disease progression. This pattern of association is not likely the result of change in behaviour because of undiagnosed disease, but more likely a change in health-seeking behaviour because of family history of disease. We explored the prevalence of screening among cases with and without a family history of colorectal cancer and observed that cases with a family history of colorectal cancer had approximately twice as much screening as cases without a family history of colorectal cancer. The pattern of association is less marked in women, possibly because of rather low overall screening sigmoidoscopy rates reported by women in the study. Given the pattern that we observed, it is possible that associations with family history are overestimated by exclusion of those diagnosed at a more advanced disease stage.
Accepting that errors in measurement occur, it is important to identify methods to deal with these sources of error. Perhaps the greatest source of errors in measurement comes from obtaining exposure data for a non-disease-free time period among those diagnosed at an advanced stage of the disease process. In many instances the most relevant referent period is unknown, thus by using lifetime or long-term exposure variables, such as longterm physical activity, the impact of behaviour change because of disease may be less. However, for many exposures such as dietary intake, it is difficult to measure lifetime consumption patterns. It is possible that cases be asked a referent period specific to their disease stage; if such practices were used, it would be imperative that matched controls be asked to recall the same referent period as cases. In the cohort study, options to model time between exposure and disease diagnosis are possible, which take into account the variability in the time between exposure and disease stage at diagnosis.
In summary, most factors associated with colon cancer in these data do not appear to differ by stage at time of diagnosis, thus impact on associations associated with selection bias may be minimal. However, it does appear that the disease process may have an impact on our ability to measure accurately exposures such as smoking cigarettes, drinking alcohol, and consuming certain types of food and total energy. In these instances, it is feasible that errors in measurement are introduced by failure to obtain exposure information during a cancer-free time. The result of these errors in measurement are most likely, missed or underestimated associations with disease.
